REFLECTIONS. Scientific journal of Eugenio Espejo Hospital

PUBLICATION STANDARDS MEDICAL JOURNAL REFLEXIONS

 

EDITORIAL SCOPE AND POLICY

The Reflexiones Medical Magazine (abbreviated title: Rev. Med Reflexiones) is a scientific publication of the Eugenio Espejo Quito Specialty Hospital [www.hee.gob.ec] and is indexed in the LILACS databases (Latin American and Caribbean Literature in Health Sciences). Original works and other scientific communications are published on topics of medical and health science interest. Its International Standard Serial Number (ISSN) is: 1390-4353.

The financing of the magazine comes from the institution's own funds and its distribution is free to health professionals, students and libraries.

Currently the periodicity of the magazine is semiannual, but with plans to increase to quarterly editions in the coming years. The main format of the magazine is printed, but the digitized versions will be available for free download on the web: www.hee.gob.ec

Rev. Med Reflexiones tries to closely follow the guidelines of the “International Committee of Medical Journal Editors” [ICMJE – web: http://www.icmje.org], regarding the “Uniformity requirements for manuscripts submitted to biomedical journals”, whose version translated into Spanish can be freely downloaded from the UAB website [www.metodo.uab.cat]. Likewise, it seeks to follow the recommendations of the databases in which it is indexed and the Virtual Health Library (VHL) of Ecuador.

The general information and guidelines necessary for the preparation of manuscripts before submission to Revista Médica Reflexiones are described below.

1. TYPES OF ARTICLES AND SECTIONS OF THE MAGAZINE

Rev. Med Reflexiones accepts articles that have not been previously published in other journals, prepared with adequate scientific content and good methodological rigor, to be published in the following sections:

1. Original articles:They are contributions from new research conducted with observational, experimental or evidence integration designs. They will have between 3500 and 5000 words, without considering the summary and bibliographic references and a maximum of 6 tables and/or figures. Clinical trials as well as meta-analyses and systematic reviews must comply with the CONSORT regulations.
2. Case Reports:They are original contributions corresponding to the description and clinical analysis of individual subjects or groups of patients (in a number equal to or less than 10 subjects) with a common characteristic. They will be between 2000 and 2500 words, unless greater content is justified; as well as a maximum of 4 tables and/or figures and 15 bibliographical references. Cases suitable for publication do not necessarily have to be rare; they may be conditions with unusual forms of presentation, management or evolution. They usually fall into the categories described below: a) new condition or disease, b) rare, uncommon and poorly reported condition, c) unusual presentation of a common disease, d) unexpected association between unusual symptoms and signs, e) impact of a disease in the evolution of another, f) unusual evolution or unexpected event in the course of an observation or treatment, g) impact of the treatment of one condition on another, h) unexpected complications of procedures or treatments (undescribed side effects), i ) new and “unique” diagnostic treatments or procedures.
3. Editorials*:These are usually works requested directly from experts by those responsible for the edition, although spontaneous contributions are not excluded, for which prior agreement should be established. They will have a maximum length of 2000 words, with two possible tables and two figures and a maximum of 30 bibliographical references.
4. Scientific letters:They are original contributions corresponding to research and case reports, presented in short manuscripts given their methodological complexity and/or scope of results. They will have a maximum of 1000 words, a table and a figure and 10 bibliographical references.
5. Letters to the editor:They are contributions corresponding to comments or criticisms on published articles; or scientific communications on different topics, not related to previously published articles. It will have a maximum of 1000 words, a table and/or figure and 10 bibliographical references (including that of the published article being discussed, if this is the reason for the letter).
6. Clinical Practice Guides*:They are contributions corresponding to scientific reviews, summaries of evidence and management protocols, related to specific clinical situations. It will be between 4000 and 5000 words, without considering summary and bibliographic references; a maximum of 6 tables and/or figures, unless a larger number is justified; The number of references must be according to the content and length of the manuscript.
7. Revisions*:They are contributions corresponding to scientific reviews and summaries of evidence, related to biomedical topics for updating and continuing medical education; which will be limited to topics of great scientific interest, new discoveries, controversial management of diseases, rare diseases (infrequent), diseases that cause current epidemics, etc. It will be between 4000 and 5000 words, without considering summary and bibliographic references; a maximum of 6 tables and/or figures, unless a larger number is justified; The number of references must be according to the content and length of the manuscript. Medical images: These are images illustrative of clinical aspects. They will have a maximum length of 300 words, describing the clinical condition that is presented; with a maximum of 3 figures/photographs and 2 bibliographical references.

* Editorial articles, clinical reviews and other special articles from non-regular sections may only be presented under the explicit invitation of the Editor-in-Chief and/or Editorial Board of the journal.

Currently, the magazine prioritizes the publication of original articles. For this reason, original articles will occupy 50% or more of the total articles published in each issue of the magazine.

1. PREVIOUS, DUPLICATE AND REDUNDANT PUBLICATIONS.

Reflexiones Medical Journal will not accept manuscripts that have been submitted simultaneously to other biomedical journals (duplicate submission), or that have been accepted for publication in another journal. In the event of detection of any of these circumstances, legal actions may be taken that are considered appropriate.

Nor will it accept articles as redundant or duplicate publications (those articles that substantially coincide with one already published in printed or electronic version), unless re-publication is specified by decision of the author and editor, due to scientific dissemination priorities and of public health, and provided that there is written authorization from the journal responsible for the original publication.

Authors may submit for review complete articles that have previously had partial presentations such as: presentations of preliminary results or summaries in poster form, communications at scientific conferences, thesis dissertations, or summary-type publications in minutes of scientific meetings or in formats. Similar. In all these cases, the authors must detail the modality and place of the communication or partial presentation made and certify that the work in full has not been previously published.

In the case of articles directly related to previous complete publications, made in another journal on the same topic or research, the title of the new article must clearly describe that it is a continuation.

The preliminary dissemination, generally through the media, government agencies, or manufacturers, of the scientific information contained in an accepted but not yet published article, represents a violation of the editorial policy followed by many journals.

This disclosure can be defended when the article describes important therapeutic advances or risks to public health such as adverse effects of drugs, vaccines, other biological products, or medical devices, or notifiable diseases. This disclosure should not compromise the publication, although this aspect must be discussed and agreed upon in advance with the director.

Work derived from the analysis of secondary databases must also specify the origin of the database and, if it is not a public database, the publications of the research that gave rise to the database must be cited. data and those derived from its secondary exploitation.

Likewise, authors can also submit to Rev. Med Reflexiones for evaluation, articles not accepted by other journals (attaching their editorial comments).

• SECONDARY PUBLICATION ACCEPTABLE

Secondary publication in the same or another language, especially in other countries, is justified and may be beneficial if the following conditions are met:

• That the authorization of the directors of both magazines be available; The director of the magazine that is going to publish the secondary publication will have a photocopy, reprint or original of the original version. In this case, the priority of the original publication will be respected, allowing an interval of at least one week to pass before the publication of the second version (unless both directors decide otherwise).
• If the secondary publication article is aimed at a different group of readers, a condensed version is usually sufficient. In this case, the secondary version must faithfully reflect the data and interpretations of the original. A footnote on the first page of the secondary version must inform readers, reviewers and documentation centers that the article has already been published in whole or in part and must state the original reference. An appropriate text for such a note may be as follows: “This article is based on a study originally published in (journal title and full reference).”
• Permission or authorization for secondary publication is free of charge.

 

1. OTHER GENERAL CONSIDERATIONS

 

1. Investigation Record

In accordance with the current regulations of the Ministry of Public Health (MSP) of Ecuador, clinical trials carried out in the country must indicate that they have the respective ministerial approval and registration. The process can be consulted on the website of the National Agency for Health Regulation, Control and Surveillance (ARCSA), at the following link: http://www.controlsanitario.gob.ec/ensayos-clinicos/.

Clinical trials not carried out in Ecuador must indicate the international registration number of the study (if they have one) and the ethics committee responsible for approval.

Rev. Med Reflexiones recommends that the authors also carry out the registration and approval process for observational studies to be carried out in the country. The process can be completed on the website of the National Directorate of Health Intelligence: http://www.salud. gob.ec/health-intelligence-direction/

1. Protection of patients participating in research

When reporting experiments with human beings, the authors must indicate whether the procedures followed comply with the ethical principles of the commission responsible for human experimentation (institutional and national) and the Declaration of Helsinki. If there is any doubt about whether the research was carried out in compliance with the Declaration of Helsinki, the authors should explain the reasons for their methodology and demonstrate that their institution's ethics committee approved the questionable aspects of the study.

Patients have the right to privacy, which should not be infringed without the respective informed consent. Everything that refers to the possible identification of the person, including the names or initials of the patients or the medical record number, must not be published. Neither photographs (obscuring the ocular region in photographs of patients is not an adequate protection to preserve anonymity) nor genealogical data should be presented, unless such information is essential for scientific objectives and the patient – ​​or his or her parent or guardian – give written consent for publication. Informed consent for this purpose requires presenting the patient with the manuscript that plans to be published. The article must indicate whether the respective informed consent of the patients has been obtained.

In the case of carrying out experiments with animals, the authors must indicate whether the national and institutional regulations for the care and use of laboratory animals have been complied with.

1. From the authors

An “author” is generally considered to be someone who has made substantive intellectual contributions to a published work. The number of authors must be in sync with the complexity and scope of the work or research carried out. The degree of participation of the different authors must be sufficient to publicly accept responsibility for the part of the content under their responsibility.

The degree of contribution must be declared for each of the authors, mainly in original research articles, taking into account at least the following criteria:

1) Important contributions in the idea and design of the study, data collection, analysis and interpretation of data.

2) Writing the draft of the article or critically revising its content with substantial intellectual input.

3) Final approval of the version to be published. Authors should meet conditions 1, 2 and 3, although possibly with different degrees of contribution, which could be useful to define the order of mention if this has not been predefined.

All contributors who do not meet the authorship criteria must appear in the acknowledgments section.

1. Of the units of measurement

Measurements of length, height, weight and volume must be given in metric units (meter, kilogram or liter) or in decimal multiples or submultiples. Temperatures must be expressed in degrees Celsius. Blood pressure should be measured in millimeters of mercury. For hematological, clinical chemistry, or other measurements, use International System of Units (SI) units; if appropriate, alternative units of measurement can be included in parentheses.

1. From the use of abbreviations and symbols

The first time an abbreviation is used it must be preceded by the unabbreviated term, unless it is a standard unit of measurement. Only standard abbreviations should be used. Avoid using abbreviations in the title. For more information, consult the “Uniformity requirements for manuscripts submitted to biomedical journals”, established by the International Committee of Medical Journal Editors, available at: http://www.icmje.org.

1. MANUSCRIPT PREPARATION

All manuscripts will comply with the publication standards established by Rev. Med Reflexiones. The manuscript will be written in Spanish and will be accompanied by a translation of the title, abstract and keywords into English. All manuscripts will be submitted in Times New Roman 12 font, written on one side, double spaced and with justified text, with 2.5 cm margins and numbered pages, following the order described below:

Title page: Where the following is included: a) the title of the work; b) name and academic degree (MD, PHD, etc.) of each of the authors with their respective institutional affiliation (Department or work area, institution, city, country); c) Corresponding author

(Indicate the name, postal address, telephone and fax numbers, and email address of the author who will be responsible for correspondence about the manuscript, including the review processes and sending comments to reviewers); d) Word count of the summary; e) Word count of the main body of the text (not including summary, bibliography, tables and figures).

Summary: All articles must be submitted with a summary in Spanish of a maximum of 250 words and its translation into English. For original articles, this should be structured with the following segments: Introduction, Objective, Design, Place and subjects, Main measurements, Results and Conclusion. For brief investigations, the structure may be limited to: Objective, Methods, Results and Conclusion. For case reports, the structure will contain: Context, Case Presentation and Conclusion. In review articles and similar articles, the summary must be in narrative format. Scientific letters and letters to the editor do not require an abstract. The summary should not contain information not included within the body of the article, nor bibliographic references.

Keywords: After the summary, between 3 and 7 keywords or short phrases should be included, which summarize the main themes of the article and allow it to be indexed. It is recommended to use the terms that appear in the Medical Subject Headings (MeSH) of the Index Medicus, available at http://www.nml.nhi.gov/mesh/meshhome.htlm Alternatively, the DeCS Descriptors in Health Sciences could be used (DecS) applied by several Latin American magazines, available at http://decs.bvs.br

Body of the manuscript: The structure and length of the manuscript will vary depending on the type of article submitted.

In original research this should have the IMRD structure: Introduction, Subjects and methods, Results and Discussion. This structure is the direct reflection of the scientific research process. The presence of subsections on methods, results and discussion can be useful to clarify its content and guide reading in long manuscripts.

As a guide, the parts of the manuscript are described in more depth:

• Introduction: The introduction should express the context or background of the study (for example, the nature of the problem and its importance) and state the specific purpose or objective of the research or the hypothesis that is tested in the study or observation. . Both primary and secondary objectives should be clearly formulated. Only references that are strictly relevant should be included and no data or conclusions should be added to the work presented.
• Subjects and methods: This section should clearly state how the study was carried out. Information must be provided on the population, place and dates of the study, as well as the ethics committee responsible for approving the protocol. Among other aspects, the selection of subjects must be described, including inclusion, exclusion, withdrawal and obtaining informed consent criteria. Methods, variables, instruments, and procedures should be reported in sufficient detail to allow others to judge the validity of the measurements and even reproduce the results. The interventions, medications and chemicals used, including generic names, doses and routes of administration, must be fully detailed. The statistical methods used must also be described, including the assumptions for calculating the sample size. These should have sufficient detail so that an expert reader with access to the original data can verify the results presented. Where possible, quantify the findings and present their effect size measures with appropriate error or uncertainty measurement indicators (such as 95% confidence intervals). Specify the techniques used for statistical analysis and the software used. Authors of meta-analyses and systematic reviews must describe the methods used to locate, select, extract, and synthesize the data. These methods should also be summarized in the summary.
• Results: Present the results following a logical sequence in the text, tables and illustrations, highlighting the most important findings first. Do not repeat data from tables or illustrations in the text. Extra or supplementary materials and technical details (such as data collection forms or surveys) can be placed in an annex where they can be consulted without interrupting the sequence of the text. It is recommended that you present the absolute values ​​from which the results were calculated and not just the derived values ​​(e.g. percentages)}
• Discussion: Highlight the most innovative and important aspects of the study and the conclusions that emerge from the interpretation of the results. Do not repeat in detail data or other material that appears in the Introduction or in the Results section. In the case of experimental studies it is useful to begin the discussion by briefly summarizing the main results; Next, explore possible mechanisms or explanations for those findings, compare and contrast the results with those of other relevant studies, present the limitations and strengths of the study, interpret the negative findings, and explore the implications of the results for future research and for the clinical practice. Relate the conclusions to the objectives of the study, avoiding making strong statements and drawing conclusions that are not adequately supported by the data. In particular, authors should avoid statements about economic costs and benefits unless the manuscript includes economic data with corresponding analyses. Avoid statements or allusions to aspects of the research that have not been completed. It is possible to establish new hypotheses when they have a basis, but clearly qualifying them as such.

The body of the article in case reports, reviews and similar, need another type of structure. For editorials and reviews, the body of the article will be divided into subtitles as deemed necessary by the authors. For case reports, the body of the manuscript must follow the ICD format: Introduction, Case Description and Discussion. As a guide, the parts of this type of manuscript are described in more depth:

• Introduction: It should be brief, reporting what is known about the topic in a synthetic way and giving the reasons for communicating the case. In the introduction we can also briefly describe the core of the clinical case, without providing excessive information or conclusions that make the reader lose interest.
• Description of the clinical case: It must be written in detail following a chronological order, emphasizing the novelty of the case. The writing must be descriptive, including only the objective components of the case and not subjective conditions such as comments or value judgments. The most relevant and pertinent laboratory results for the case should be included; If these are abundant, it is preferable to detail them in a table which must be cited in the text. The images included must also be mentioned in the text.
• Discussion: It should highlight the most interesting aspects of the case, highlighting its particularities or contrasts with the literature available on the subject. You can also comment on whether the case in question has generated new knowledge and what its practical usefulness may be. At the end of the discussion, at least one conclusion regarding the case should be included. It is necessary to keep in mind that the discussion is relevant only to the case that is reported and should not be used as a space for carrying out an extensive review of the literature.
• Bibliographic references: Only the number of relevant and necessary references for the specific type of article should be used. An exhaustive list of references, especially in non-review works, does not necessarily imply a great mastery of knowledge on the subject and in certain cases could denote a lack of scientific criteria to select the most appropriate and relevant ones. Whenever possible, readers should be given direct references to the original sources of the research. Avoid citing abstracts as references. Avoid citing a “personal communication” unless it provides essential information not available in a public source. The cited bibliographical references must be updated, unless it is scientifically pertinent to mention citations that have long since been published. References should be numbered consecutively after the discussion, following the order in which they are first mentioned in the text. They will never be presented as footnotes. References that are only cited in tables or figure legends should be numbered based on the sequence established by the first identification of the text of a specific table or figure. Bibliographic references must be written correctly and will be presented following Vancouver standards. Please note that references are not translated and have to follow international nomenclature. Journal titles should be abbreviated according to the Index Medicus style. The use of bibliographic managers is recommended to guarantee their correct format.

The Rev. Med Reflexiones editorial team checks the accuracy of all bibliographic citations and their relationship with the place in which they have been used within the text.

Some examples of bibliographic citations are described below.

Reference models according to the type of document

- Scientific magazine article

Burghi G, Berrutti D, Manzanares W. Tumor lysis syndrome in intensive care: diagnostic and therapeutic approach. Intensive Med. 2011 Apr;35(3):170-8

Castle M, Nájera E, Samprón N, Bollar A, Urreta I, Úrculo E. Frameless stereotactic brain biopsy: diagnostic capacity and complications. Neurosurgery. 2014 Mar;25(2):56-61.

- Online scientific journal article

Jutel M, Jaeger L, Suck R et al. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol [Internet]. Sep 2005 [cited Sep 10, 2014]; 116(3):608-13. Available at: http://dx.doi.org/10.1016/j.jaci.2005.06.004

Wolf TJ, Stift S, Connor LT, Baum C; Cognitive Rehabilitation Research Group. Feasibility of using the EFPT to detect executive function deficits at the acute stage of stroke. Work [Internet]. 2010 Aug [cited 2014 Sep 10]; 36(4):405-12. Available at: http://dx.doi.org/10.3233/WOR-2010-1045

- Book, monograph, etc.

Fletcher RH, Fletcher SW. Clinical epidemiology. 4th ed. Barcelona: Wolters Kluwer Health Spain; 2008. 269 p.

- Book, monograph, etc. online

Reidhaar-Olson JF, Rondinone CM, editors. Therapeutic Applications of RNAi: Methods and Protocols [Internet]. New York: Humana Press; 2009 [cited 10 Sep 2014]. 144 p. Available at: http://dx.doi.org/10.1007/978-1-60327-295-7

- Contribution to a collective work

Semerari A. Metacognitive disorders in personality disorders. In: Belloch Fuster A, coordinator. Treatise on personality disorders. Madrid: Synthesis; 2010. p. 221-30.

- Contribution to a collective online work

Speight J, Singh H. The Journey of the Person with Diabetes. In: Dunning T, editor. Diabetes Education: Art, Science and Evidence [Internet]. Chichester (West Sussex): Wiley-Blackwell; 2013 [cited 10 Sep 2014]. p. 12-27. Available at: http://dx.doi.org/10.1002/9781118702666

- Communication of a congress, conference, etc.

Moreno-Alemán J. The prescription of medications and health products by nursing staff. In: Adroher Biosca S et al., coordinators. International Congress The advances of Law in the face of advances in Medicine; 2008; Madrid. Cizur Menor (Navarra): Aranzadi; 2008. p. 283-300.

- Doctoral thesis, online academic work

Castañeda Fernández M. Study of microsatellites and miniSTRs of the X chromosome for forensic application [doctoral thesis on the Internet]. Santander: University of Cantabria; 2013 [cited 10 Sep 2014]. 172 p. Available at: http://hdl.handle.net/10902/3053

- Part or page of a website

Carlos III Health Institute [Internet]. Madrid: ISCIII; c2014. National Registry of Biobanks; [cited 10 Sep 2014]. [1 screen]. Available at: http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/registro-nacional-de-Biobancos-2.shtml

Complements: We consider complements to the manuscript to aspects related to the document or research presented. With the exception of conflicts of interest, the presence of acknowledgments, preliminary presentations, appendices and annexes depend on the relevance of being communicated.

• Conflicts of interest: All authors must make a declaration of possible conflicts of interest. These are personal, professional, financial or other relationships that may affect your scientific judgment. A conflict of interest exists when an author (or the institution to which the author belongs) has personal or financial relationships (also known as dual commitments, competing interests or conflict of loyalties) that could influence inappropriately ( bias) in their actions. These relationships range from those with negligible potential to those with sufficient potential to influence judgments; Not all relationships, however, involve a true conflict of interest. The potential for conflict of interest may exist whether or not a person believes that the relationship affects his or her scientific judgment. Financial relationships – such as employment, consultancy, share ownership, fees received, reports, expert opinions, etc. – must be fully described in the corresponding section of the article.
• Acknowledgments: Mention to the people, institutions, departments that collaborated directly or indirectly with the work. Sources of financing and subsidies must also be mentioned in this section.
• Financing: Declaration of the sources of financing, subsidies or economic funds received for the study or work. If there are no external sources, the authors must declare the work as “self-financed” or “own funds.”
• Previous submissions: Full disclosure of preliminary submissions and previous articles that could be considered redundant publications of the same work. Appendices and annexes: The mention of the complete list of researchers in the case of works whose authorship has been expressed as a working group, can be communicated in this section. Likewise, information on meetings held during the development of clinical guidelines and the like may deserve a specific description.

Certain forms, case report notebooks or other complementary information about the work can be presented as annexes to the article.

Tables: They will be numbered with Arabic numerals, according to their order of appearance in the text. Each table will be presented on a separate sheet, after the bibliographic references. Do not include tables in the middle of the text. Tables must include a title at the top and at the bottom a description of the abbreviations used in alphabetical order or explanations about the table. For table footnotes, it is recommended to use the following symbols in this order: *, †, ‡, ¶, **, ††, ‡‡, etc. Don't forget to also describe the statistical measures presented (for example: ny %, or mean ± standard deviation, etc.) Additionally, if data from another source, whether published or unpublished, is used, appropriate permission must be obtained and mention complete source.

Remember that tables collect information concisely and present it efficiently; They also offer information with the desired degrees of detail and precision. The inclusion of data in tables and not in the text allows reducing its length, therefore do not repeat the information from the tables in the text.

Figures (graphs, diagrams or images). Photographic or microscopic images of unsatisfactory quality or insufficient demonstrative value will not be accepted. It is advisable to use JPEG or TIFF formats, with a resolution of 150 or 300 dpi (dots per inch). The size must also be 9x12 cm. Figures will be numbered with Arabic numerals, according to their order of appearance in the text. The figures must be sent in separate files for each of them and the legends of the figures will be included on a separate sheet at the end of the manuscript, identified with Arabic numbers. The abbreviations used must be identified in alphabetical order. Photographs of people must be taken in such a way that they are not identifiable or consent to their use by the person photographed will be attached. Figures showing images (radiographs, histology, photographs, etc.) must be sent as separate files in electronic JPEG format with a resolution of 150 or 300 dpi (dots per inch). Figures expressing results (bars, cakes, dot diagrams) must be sent in resolutions suitable for adjustment in diagramming. The authors must provide the source files of these figures if necessary to make editing adjustments. All figures must have their respective sequential numbering and a text at the bottom that correctly describes the aspects presented in the image; as well as marks inside to guide the reader in the detail of interest. When symbols, arrows, numbers or letters are used to identify parts of the illustrations, they must be clearly identified and explained in the legend. If necessary, the scale or reference measurements must be specified and the method of coloring the photomicrographs must be identified.

If an already published figure is used, the original source must be mentioned and written permission from the copyright owner must be presented to reproduce the material, except in the case of public domain documents.

1. SENDING OF MANUSCRIPTS

Reception of manuscripts is permanent throughout the year. The manuscripts will be delivered (two printed copies and 1 digital version on CD/DVD) to the Subdirectorate of Teaching and Research of the Eugenio Espejo Hospital addressed to Revista Médica Reflexiones. Likewise, manuscripts may be sent by email to the address Revista.reflexiones@hee.gob.ec . Manuscripts must be accompanied by a letter signed by the authors (minimum the person responsible for correspondence) requesting their consideration for possible publication and stating the following information:

• Explicit declaration that it has not been sent simultaneously to another biomedical journal, nor that it has been previously published (except for articles with preliminary presentations).
• Declaration stating that the manuscript has been read and approved by all authors, and that all authorship requirements are met as defined in these journal regulations.

The letter should also provide any additional information that may be useful to the editor, such as the topic it addresses and its relevance; preview data; etc If necessary, a copy of the authorizations to reproduce already published material, to use illustrations or to release information about identifiable people, as well as to mention certain people for their contributions, must be attached.

Once receipt of the complete documents is confirmed, Rev. Med Reflexiones will issue a certificate which will include the registration number assigned to the manuscript.

This number will be used for all documentation review and filing processes, as well as to answer queries from authors. The certification of receipt will be sent or delivered exclusively to the corresponding corresponding author.

• REVIEW PROCESS

Manuscripts that do not comply with the publication standards and format previously described will not be accepted. Upon receipt, all works will be subjected to an initial review by the editor of the journal. If it is considered necessary to make changes or corrections, these will be communicated to the corresponding author. Once the recommended corrections have been made, the manuscript goes to a peer review process with experience in publications and knowledge of Research Methodology, which may belong to the institution or other institutions. Reviewers have a period of 15 business days to review them and issue their comments. The final result will lead to the acceptance of the manuscript, its return to introduce corrections for the reworking of the work or the rejection of its publication in the Journal. The decision as well as the comments and suggestions will be informed to the corresponding author. If changes are requested in the manuscript, the authors have a maximum period of 30 days to send them, which must be accompanied by a letter responding, point by point, to each of the comments issued by the reviewers or the editorial board. Once this process is completed, the editorial committee meets, analyzes and makes the final approval or not of the articles.

• PUBLICATION AND COPYRIGHT

Accepted manuscripts will remain the property of Rev. Med Reflexiones, but the author will retain his intellectual property rights.

Before publishing an accepted article, it will be subjected to an editing process for grammatical correction, narrative style and specific content adjustments (including possible reduction in length) but respecting at all times the essence of the original. The corresponding author will receive a preprint proof to review and report on possible necessary amendments within a maximum period of 48 hours.

The date of publication, as well as the issue number to which the article will be assigned, depends on priorities set by the Editor.

Each author may request a printed copy of the magazine in which their article appears and will receive the digitized version of it in order to print offprints according to their personal requirements.

The Rev. Med Reflexiones is published in printed version and its contents digitized in PDF format for Acrobat, are available on the Eugenio Espejo Hospital website www.hee.gob.ec.

Discharge

The content of Revista Médica Reflexiones is under a Creative Commons Attribution-ShareAlike 4.0 international license, for this reason it does not ask or require financial payments for application, processing, publication or any other step that is part of the editorial process.

Likewise, this journal provides immediate open access to its content, based on the principle that offering the public free access to research helps promote greater global exchange of knowledge.

The contents published during the institutional life of Revista Médica Reflexiones will be permanently on the web portal.https://rev-reflexiones.hee.gob.ec/ojs-3.1.2/index.php/reflexiones/inicioand its access will be free, without any type of economic restriction, likewise the technology used for its dissemination will be standard and friendly with most operating systems.

Content exploitation rights

Reflections Medical Magazineretains the copyright of the published works, and encourages and allows their reuse under the Creative Commons Attribution-ShareAlike 4.0 license, for this reason it does not ask or require financial payments for application, processing, publication or any other step. make it part of the editorial process.

Likewise, this journal provides immediate open access to its content, based on the principle that offering the public free access to research helps promote greater global exchange of knowledge.

The articles published here can be copied, used, disseminated, transmitted and displayed publicly, as long as the authorship and the original source of their publication are cited (magazine, publisher and URL of the work) and the existence and specifications of this license are mentioned. of use.